Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for ovarian cancer, familial, susceptibility to, 1 has been reported in the published literature.
No clinical trials have been registered for ovarian cancer, familial, susceptibility to, 1.
163 publications have been identified in PubMed for ovarian cancer, familial, susceptibility to, 1. Kisho has analyzed 129 by research type. Research spans Epidemiology / Natural History (30%), Diagnostic / Biomarker (19%), and Basic Science / Preclinical (18%).
Research Type | Count | % of Total |
|---|---|---|
Disease patterns and progression | 39 | 30% |
Data assembled from 2 of 12 sources · Last updated Sep 20, 2026, 5:42 PM UTC
Testing and diagnosis research |
24 |
19% |
Laboratory research | 23 | 18% |
Research summaries | 21 | 16% |
Clinical study results | 12 | 9% |
New treatment approaches | 4 | 3% |
Other research | 3 | 2% |
Patient case studies | 3 | 2% |
Patel K (2026). [PMID: 41215703](https://pubmed.ncbi.nlm.nih.gov/41215703/). *Cancer Prev Res (Phila)*. [Diagnostic / Biomarker]
Lee EJ (2026). [PMID: 41943275](https://pubmed.ncbi.nlm.nih.gov/41943275/). *J Korean Med Sci*. [Diagnostic / Biomarker]
Ebata A (2026). [PMID: 41093592](https://pubmed.ncbi.nlm.nih.gov/41093592/). *Tohoku J Exp Med*. [Epidemiology / Natural History]
Yamada A (2026). [PMID: 41342555](https://pubmed.ncbi.nlm.nih.gov/41342555/). *Jpn J Clin Oncol*. [Case Report / Case Series]
Noronha MM (2026). [PMID: 41493663](https://pubmed.ncbi.nlm.nih.gov/41493663/). *Fam Cancer*. [Epidemiology / Natural History]
Fergus KB (2026). [PMID: 41385723](https://pubmed.ncbi.nlm.nih.gov/41385723/). *JAMA Intern Med*. [Clinical Trial Publication]
Saule C (2026). [PMID: 41818853](https://pubmed.ncbi.nlm.nih.gov/41818853/). *Gynecol Oncol*. [Clinical Trial Publication]
Gandhi A (2026). [PMID: 41637687](https://pubmed.ncbi.nlm.nih.gov/41637687/). *J Clin Oncol*. [Epidemiology / Natural History]
Daly MB (2026). [PMID: 41915393](https://pubmed.ncbi.nlm.nih.gov/41915393/). *JAMA Netw Open*. [Diagnostic / Biomarker]
Ganesan S (2026). [PMID: 41707894](https://pubmed.ncbi.nlm.nih.gov/41707894/). *Am J Obstet Gynecol*. [Review / Meta-Analysis]